Close

ESG Data

[Notes]
*The coverage of environmental accounting includes the Head Office Plant of Mochida Pharmaceutical Plant Co., Ltd.

*The coverage of social data is non-consolidated.

*The coverage of governance data is non-consolidated.

Environment

Category Coverage*1 FY2022 FY2023 FY2024
CO2 emissions*2
Total(t-CO2 a,b,c,d 16,685 15,142 12,956
- Plants and research centers(t-CO2 14,153 12,868 10,690
- Office(t-CO2 591 460 401
- Commercial fleet(t-CO2 1,941 1,814 1,865
CO2 emissions by Scope*3
Scope 1(t-CO2 a,b,c 4,313 4,017 4,350
Scope 2(t-CO2 10,431 9,311 6,742
Scope 3
- Category 1:Purchased goods and services(t-CO2
- - 177,614 159,554
- Category 2:Capital goods(t-CO2 - 3,634 4,401
- Category 5:Waste generated in operations(t-CO2 320 338 316
- Category 6:Business travel(t-CO2 1,236 2,077 1,880
- Category 7:Employee commuting(t-CO2 695 700 699
- Category 8:Upstream leased assets(t-CO2 1,941 1,814 1,865
- Category 12:End-of-life treatment of sold products(t-CO2 250 258 261
Energy
Total(GJ) a,b,c,d 353,482 347,617 317,249
- Electric power purchased(GJ) 236,980 235,290 204,879
- Heavy oil A(GJ) 0 0 0
- Gasoline(GJ) 28,926 27,029 27,207
- LNG(GJ) 65,242 63,692 65,363
- City gas(GJ) 22,324 21,579 19,786
- LPG(GJ) 10 27 15
- Steam(GJ) 0 0 0
Water resources*4
Water consumption(Thousand m3 a,b,c 348 306 347
- Groundwater(Thousand m3 344 301 342
- Public water(Thousand m3 4 5 5
Amount of wastewater(Thousand m3 310 306 321
- Sewerage(Thousand m3 13 15 10
- Other(Thousand m3 297 291 311
Water pollution*4
BOD emissions(t) a,b,c 0.8 0.5 0.4
COD emissions(t) 0.4 0.4 0.4
SS emissions(t) 0.5 0.5 0.4
Waste*4
Waste generated(t) a,b,c 524 533 511
External recycled waste(t) 520 529 507
External recycled waste rate(%) 99.2 99.3 99.2
Final disposal(t) 4 4 4
Final disposal rate(%) 0.76 0.75 0.78
OA paper(Ten thousand sheets) 1,196 1,103 929
Air pollution
Particulate matter emissions(t) a,b,c 0 0 0
SOx emissions(t) 0 0 0
NOx emissions(t) 0 0 0
PRTR discharge*5
Handled emissions(t) a,b,c 1.5 0.2 0.4
Released into the atmosphere*6(t) 0 0 0
Released into water*6(t) 0 0 0
Transferred to sewerage*6(t) 0 0 0
Transferred to waste(t) 1.5 0.2 0.4
Containers and package
Container and package recycling(t) a,c 135 129 138
Environmental laws
Violation(Cases) a,b,c,d 0 0 0

*1
a.Mochida Pharmaceutical Co., Ltd.
b.Head Office Plant of Mochida Pharmaceutical Plant Co., Ltd.
c.Saitama Plant of Mochida Pharmaceutical Plant Co., Ltd.
d.Commercial fleet.
*2 The CO2 emissions from electricity will be calculated using the adjusted emission factor.
*3 The CO2 emissions per scope by the GHG protocol.
*4 The branches and sales offices of Mochida Pharmaceutical Co., Ltd. are not included. Additionally, the data for FY2022 includes some data from Mochida Pharmaceutical Co., Ltd.'s headquarters, which began operations out of the new office building in September 2022.
*5 Not includes branches and sales offices of Mochida Pharmaceutical Co., Ltd., because not applicable.
*6 <1t.

Environmental accounting

Units:Thousand JPY

Category FY2024 Investments FY2024 Expenses
Environmental conservation costs*
Costs within our business areas 43,174 63,870
- Pollution prevention costs 0 46,286
- Global environmental conservation costs 43,174 1,207
- Resource recycling costs 0 16,377
Upstream & downstream costs 0 2,485
Environmental management costs 0 17,272
Environmental R&D costs 0 0
Social activity costs 5,480 581
Environmental remediation costs 0 0
Total 48,654 84,208
Category FY2023 FY2024 Y o Y
Environmental conservation benefits
CO2 emissions(t-CO2 8,879 7,118 ▲1,761
Electricity usage(Thousand kWh) 15,231 15,308 77
Heavy oil usage(kL) 0 0 0
LNG usage(t) 1,167 1,195 28
Water consumption(Thousand m3 198 238 40
Water discharge for public waters(Thousand m3 232 248 16
Waste generated(t) 302 315 13

*Include the cost for enviromental conservation;
Partially include the cost for multiple parpose, in the propotion for enviroment-purpose;
Exclude the depreciation expense for fixed asset.

Social

Category FY2022 FY2023 FY2024
Employees information
Number of employees(Consolidated)(Persons) 1,529 1,522 1,508
Number of employees(Persons) 1,252 1,247 1,237
- Female(Persons) 378 385 391
Number of managers(Persons) 251 294 322
- Female(Persons) 30 34 38
Ratio of female managers(%) 12.0 11.6 11.8
- Target*1(%) 12.0 12.0 12.0
Number of new recruits(Persons) 37 34 34
- Female(Persons) 23 18 16
Number of mid-career hires(Persons) 20 33 37
- Female(Persons) 3 9 9
Ratio of mid-career hires(%) 35.1 49.3 52.1
Ratio of disabled employees(%) 2.4 2.4 2.53
Average age(Years) 42.4 42.8 43.3
Average years of service(Years) 16.8 16.9 17.0
- Male(Years) 17.7 17.8 17.9
- Female(Years) 14.7 15.0 15.0
Difference in average years of service between male and female(Years) 3.1 2.8 2.9
Average annual salary(JPY) 8,330,221 8,223,301 8,251,926
Gender pay gap*2 All workers(%) 70.5 70.5 69.7
- Regular workers (%) 72.3 72.0 70.9
- Part-time and fixed-term workers(%) 53.9 54.6 62.7
Human resources development
Retention rate after 3 years(%) 95.2 86.8 97.3
Staff turnover rate*3(%) 3.4 3.2 4.5
Work-life balance
Number of employees who took holidays before and after childbirth leave(Persons) 16 19 13
Number of employees who took childcare leave(Persons) 40 48 38
- Female(Persons) 12 20 17
Ratio of male employees who took childcare leave(%) 75.6 76.9 77.7
Ratio of female employees who took childcare leave(%) 100 100 100
Number of employees using short-time work for childcare(Persons) 37 36 43
Ratio of returning to work after childcare leave(%) 97.4 100 94.4
Occupational health and safety
Number of days of paid leave granted(Days) 19.2 19.2 19.2
Average usage of paid leave(Days) 12.0 12.8 12.2
Ratio of paid leave acquisition(%) 62.5 66.8 63.6
Average actual hours worked per year(Hours) 2,028 2,013 2,011
Average overtime hours per month(Hours) 6.4 5.9 6.3
Accident frequency rate*4 0 0.33 0
Employee stock ownership association
Number of members(Consolidated)(Persons) 591 583 567
Labor union
Number of members(Consolidated)(Persons) 996 986 962
Donations
Grant for study*5(Million JPY) 260 238 -

*1 The goals by the end of fiscal year 2025.
*2 Ratio of the average annual salary of female employees to the average annual salary of male employees.
*3 Except for retired and a loan employee.
*4 Number of deaths and injuries by Industrial accident/Total number of actual working hours×1,000,000.
*5 Except for Conference co sponsorship fee.

Governance

Category FY2022 FY2023 FY2024
Board of Directors
Number of the Board(Persons) 10 11 11
- Outside members(Persons) 3 4 4
- Female members(Persons) 1 1 1
Audit & Supervisory Board
Number of Audit & Supervisory Board members (Persons) 5 5 5
- Outside members(Persons) 3 3 3
- Female members(Persons) 1 1 1
Officers' compensation of directors
Total(Million JPY) 347 272 304
Officers' compensation of Audit & Supervisory Board member
Total(Million JPY) 65 65 64
Nomination and Compensation Advisory Committee
Ratio of Independent board member(%) 66.6 66.6 66.6
Meeting frequency
Board of Directors(Times) 13 14 14
Audit & Supervisory Board(Times) 16 16 16
Page top